Role of Sostdc1 in skeletal biology and cancer
暂无分享,去创建一个
Xi Chen | Jiake Xu | Chenyu Zhu | Mei Huang | Lifei Liu | Xiaoyang Tong | Jun Zou
[1] M. Brandi,et al. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders , 2022, Osteoporosis International.
[2] H. Xin,et al. SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β‐catenin pathway , 2022, Environmental toxicology.
[3] J. Lee,et al. USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction , 2022, Cell Death & Disease.
[4] Zhiying Zhao,et al. Exosomal circ_0001190 Regulates the Progression of Gastric Cancer via miR-586/SOSTDC1 Axis , 2022, Biochemical Genetics.
[5] H. Kwon,et al. MSX1 Drives Tooth Morphogenesis Through Controlling Wnt Signaling Activity , 2022, Journal of dental research.
[6] Ran Wang,et al. Proteomic profiling identifies novel diagnostic biomarkers and molecular subtypes for mucinous tubular and spindle cell carcinoma of the kidney , 2022, The Journal of pathology.
[7] R. Swaminathan,et al. Identification and validation of plasma biomarkers for diagnosis of breast cancer in South Asian women , 2022, Scientific Reports.
[8] Weihui Chen,et al. Revitalizing mouse diphyodontic dentition formation by inhibiting the sonic hedgehog signaling pathway , 2021, Developmental dynamics : an official publication of the American Association of Anatomists.
[9] Yueping Chen,et al. Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/β-catenin pathways in osteonecrosis of the femoral head , 2021, Saudi Pharmaceutical Journal : SPJ.
[10] W. Yue,et al. Uterine Sensitization-Associated Gene-1 in the Progression of Kidney Diseases , 2021, Journal of immunology research.
[11] Qian Liu,et al. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway , 2021, Cell cycle.
[12] Y. Tabata,et al. Anti–USAG-1 therapy for tooth regeneration through enhanced BMP signaling , 2021, Science Advances.
[13] D. Pe’er,et al. Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung , 2020, bioRxiv.
[14] X. Bian,et al. SOSTDC1-producing follicular helper T cells promote regulatory follicular T cell differentiation , 2020, Science.
[15] J. Casal,et al. SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166 , 2020, Oncogene.
[16] Chandramohan Kattamuri,et al. Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST , 2020, The Biochemical journal.
[17] Faping Li,et al. Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer. , 2020, International immunopharmacology.
[18] E. Cho,et al. Suppression of Hedgehog signaling is required for cementum apposition , 2020, Scientific Reports.
[19] G. Mortier,et al. WNT Signaling and Bone: Lessons From Skeletal Dysplasias and Disorders , 2020, Frontiers in Endocrinology.
[20] Aijie Chen,et al. The Role of Tantalum Nanoparticles in Bone Regeneration Involves the BMP2/Smad4/Runx2 Signaling Pathway , 2020, International journal of nanomedicine.
[21] S. Seno,et al. In vivo dynamic analysis of BMP-2-induced ectopic bone formation , 2020, Scientific Reports.
[22] K. Lam,et al. The BMP antagonist, SOSTDC1, restrains gastric cancer progression via inactivation of c-Jun signaling. , 2019, American journal of cancer research.
[23] Cheng Ren,et al. MiR-26a promotes fracture healing of nonunion rats possibly by targeting SOSTDC1 and further activating Wnt/β-catenin signaling pathway , 2019, Molecular and Cellular Biochemistry.
[24] P. Croucher,et al. Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells , 2019, Bone.
[25] G. Loots,et al. Sostdc1 Regulates NK Cell Maturation and Cytotoxicity , 2019, The Journal of Immunology.
[26] J. O. Manilay,et al. Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies , 2019, Current Osteoporosis Reports.
[27] R. Krumlauf,et al. Shh Plays an Inhibitory Role in Cusp Patterning by Regulation of Sostdc1 , 2018, Journal of dental research.
[28] Jianru Xiao,et al. SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target , 2018, International journal of molecular medicine.
[29] Jiadong Wang,et al. E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin , 2018, Cell Death & Disease.
[30] B. Ozgul,et al. Investigation of SOSTDC1 gene in non-syndromic patients with supernumerary teeth , 2018, Medicina oral, patologia oral y cirugia bucal.
[31] M. Dixon,et al. Ectopic Hedgehog Signaling Causes Cleft Palate and Defective Osteogenesis , 2018, Journal of dental research.
[32] L. Hood,et al. Population-specific genetic modification of Huntington's disease in Venezuela , 2018, PLoS genetics.
[33] Wenbo Hao,et al. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer , 2018, BMC Cancer.
[34] Roy S. Herbst,et al. The biology and management of non-small cell lung cancer , 2018, Nature.
[35] Jiadong Wang,et al. SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways , 2017, Molecular and Cellular Biochemistry.
[36] Motoko Yanagita,et al. Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development , 2016, PloS one.
[37] G. Loots,et al. Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells. , 2016, Bone.
[38] Katsu Takahashi,et al. Effects of Usag-1 and Bmp7 deficiencies on murine tooth morphogenesis , 2016, BMC Developmental Biology.
[39] H. Guan,et al. SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation , 2016, Cell & Bioscience.
[40] Vicki Rosen,et al. BMP signalling in skeletal development, disease and repair , 2016, Nature Reviews Endocrinology.
[41] L. Miller,et al. Hepcidin regulation in prostate and its disruption in prostate cancer. , 2015, Cancer research.
[42] Rajkumar Thangarajan,et al. E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells , 2014, Cellular Oncology.
[43] Yasuhiko Tabata,et al. Interactions between BMP-7 and USAG-1 (Uterine Sensitization-Associated Gene-1) Regulate Supernumerary Organ Formations , 2014, PloS one.
[44] R. Krumlauf,et al. Wise Regulates Bone Deposition through Genetic Interactions with Lrp5 , 2014, PloS one.
[45] G. Loots,et al. Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner☆ , 2013, Developmental biology.
[46] T. Rajkumar,et al. SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer. , 2013, Cancer genetics.
[47] T. Mueller,et al. Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling , 2013, PloS one.
[48] Christof Niehrs,et al. Secreted and transmembrane wnt inhibitors and activators. , 2013, Cold Spring Harbor perspectives in biology.
[49] Jiake Xu,et al. An overview of the regulation of bone remodelling at the cellular level. , 2012, Clinical biochemistry.
[50] G. Seki,et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13–USAG-1 pathway , 2012, Laboratory Investigation.
[51] L. Miller,et al. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer , 2011, Breast Cancer Research and Treatment.
[52] C. Tickle,et al. Interactions between Shh, Sostdc1 and Wnt signaling and a new feedback loop for spatial patterning of the teeth , 2011, Development.
[53] Zhenlin Zhang,et al. Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men , 2011, Journal of Bone and Mineral Metabolism.
[54] M. Willingham,et al. Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors , 2010, Journal of experimental & clinical cancer research : CR.
[55] R. Krumlauf,et al. Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning , 2010, Development.
[56] G. Loots,et al. Genetic evidence that SOST inhibits WNT signaling in the limb. , 2010, Developmental biology.
[57] T. Sakurai,et al. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. , 2010, The Journal of clinical investigation.
[58] Y. Arai,et al. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor , 2009, Genes, chromosomes & cancer.
[59] J. Saldanha,et al. Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP Signals* , 2009, The Journal of Biological Chemistry.
[60] E. Järvinen,et al. Tinkering with the inductive mesenchyme: Sostdc1 uncovers the role of dental mesenchyme in limiting tooth induction , 2009, Development.
[61] M. Ota,et al. Lrp4 Modulates Extracellular Integration of Cell Signaling Pathways in Development , 2008, PloS one.
[62] Katsu Takahashi,et al. Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. , 2008, Biochemical and biophysical research communications.
[63] A. Murphy,et al. Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury. , 2008, Kidney international.
[64] M. Willingham,et al. A human bone morphogenetic protein antagonist is down-regulated in renal cancer. , 2007, Molecular biology of the cell.
[65] Katsu Takahashi,et al. Rudiment incisors survive and erupt as supernumerary teeth as a result of USAG-1 abrogation. , 2007, Biochemical and biophysical research communications.
[66] Scott Saunders,et al. Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[67] O. MacDougald,et al. Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.
[68] G. Beaudoin,et al. Hairless triggers reactivation of hair growth by promoting Wnt signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[69] Nobuyuki Itoh,et al. Regulation of Mammalian Tooth Cusp Patterning by Ectodin , 2005, Science.
[70] Xi He,et al. SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor* , 2005, Journal of Biological Chemistry.
[71] M. Yanagita. BMP antagonists: their roles in development and involvement in pathophysiology. , 2005, Cytokine & growth factor reviews.
[72] R. Baron,et al. Interaction between LRP5 and Frat1 Mediates the Activation of the Wnt Canonical Pathway* , 2005, Journal of Biological Chemistry.
[73] M. Katoh,et al. Identification and characterization of human CKTSF1B2 and CKTSF1B3 genes in silico. , 2004, Oncology reports.
[74] A. Niida,et al. USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. , 2004, Biochemical and biophysical research communications.
[75] Nobuyuki Itoh,et al. Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. , 2003, Developmental biology.
[76] Hyo-Sang Park,et al. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. , 2003, Biochemical and biophysical research communications.
[77] Alison Rowe,et al. Wise, a context-dependent activator and inhibitor of Wnt signalling , 2003, Development.
[78] Jae-Hyun Sung,et al. BMP-2-induced Runx2 Expression Is Mediated by Dlx5, and TGF-β1 Opposes the BMP-2-induced Osteoblast Differentiation by Suppression of Dlx5 Expression* , 2003, Journal of Biological Chemistry.
[79] Nobuyuki Itoh,et al. Sclerostin Is a Novel Secreted Osteoclast-derived Bone Morphogenetic Protein Antagonist with Unique Ligand Specificity* , 2003, Journal of Biological Chemistry.
[80] D. Simmons,et al. Uterine Sensitization-Associated Gene-1: A Novel Gene Induced Within the Rat Endometrium at the Time of Uterine Receptivity/Sensitization for the Decidual Cell Reaction1 , 2002, Biology of reproduction.
[81] Jeffrey R. Miller,et al. The Wnts , 2001, Genome Biology.
[82] B. Hogan,et al. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.
[83] S. Khosla,et al. Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women. , 2014, The Journal of clinical endocrinology and metabolism.
[84] R. Atit,et al. Wnt/β-catenin signaling directs multiple stages of tooth morphogenesis , 2008 .
[85] O. Avsian-Kretchmer,et al. Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. , 2004, Molecular endocrinology.